10X Genomics Strategy Driven By Innovation, CEO Says

The video discusses the launch of new products aimed at advancing biological research, emphasizing the importance of measuring cellular complexity. The company aims to become a leading global entity, with a focus on genetics and single cell research, which has significantly contributed to vaccine development. The strategy includes targeted acquisitions to drive innovation, and partnerships with mainstream pharma. The company has played a crucial role in COVID-19 research, providing tools for analyzing patient samples to understand the disease better.

What is the company's philosophy regarding acquisitions?

In what ways does the company plan to partner with mainstream pharma?